These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Determination of regions important for monoamine oxidase (MAO) A and B substrate and inhibitor selectivities. Shih JC; Chen K; Geha RM J Neural Transm Suppl; 1998; 52():1-8. PubMed ID: 9564602 [TBL] [Abstract][Full Text] [Related]
10. Investigation on the structure of the active site of monoamine oxidase-B by affinity labeling with the selective inhibitor lazabemide and by site-directed mutagenesis. Cesura AM; Gottowik J; Lahm HW; Lang G; Imhof R; Malherbe P; Röthlisberger U; Da Prada M Eur J Biochem; 1996 Mar; 236(3):996-1002. PubMed ID: 8665924 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of monoamine oxidase by indole and benzofuran derivatives. Prins LH; Petzer JP; Malan SF Eur J Med Chem; 2010 Oct; 45(10):4458-66. PubMed ID: 20674099 [TBL] [Abstract][Full Text] [Related]
13. Development of selective and reversible pyrazoline based MAO-A inhibitors: Synthesis, biological evaluation and docking studies. Karuppasamy M; Mahapatra M; Yabanoglu S; Ucar G; Sinha BN; Basu A; Mishra N; Sharon A; Kulandaivelu U; Jayaprakash V Bioorg Med Chem; 2010 Mar; 18(5):1875-81. PubMed ID: 20149663 [TBL] [Abstract][Full Text] [Related]
14. Phe(208) and Ile(199) in human monoamine oxidase A and B do not determine substrate and inhibitor specificities as in rat. Geha RM; Chen K; Shih JC J Neurochem; 2000 Sep; 75(3):1304-9. PubMed ID: 10936214 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of monoamine oxidase by selected C6-substituted chromone derivatives. Legoabe LJ; Petzer A; Petzer JP Eur J Med Chem; 2012 Mar; 49():343-53. PubMed ID: 22309913 [TBL] [Abstract][Full Text] [Related]
16. Kinetic behavior and reversible inhibition of monoamine oxidases--enzymes that many want dead. Tipton KF; Davey GP; McDonald AG Int Rev Neurobiol; 2011; 100():43-64. PubMed ID: 21971002 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of monoamine oxidase by 3,4-dihydro-2(1H)-quinolinone derivatives. Meiring L; Petzer JP; Petzer A Bioorg Med Chem Lett; 2013 Oct; 23(20):5498-502. PubMed ID: 24012182 [TBL] [Abstract][Full Text] [Related]
18. The synthesis and evaluation of sesamol and benzodioxane derivatives as inhibitors of monoamine oxidase. Engelbrecht I; Petzer JP; Petzer A Bioorg Med Chem Lett; 2015 May; 25(9):1896-900. PubMed ID: 25857942 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic, Molecular and Computational Aspects of Novel Monoamine Oxidase (MAO) Inhibitors. Ramesh M; Dokurugu YM; Thompson MD; Soliman ME Comb Chem High Throughput Screen; 2017; 20(6):492-509. PubMed ID: 28294055 [TBL] [Abstract][Full Text] [Related]
20. Towards development of selective and reversible pyrazoline based MAO-inhibitors: Synthesis, biological evaluation and docking studies. Sahoo A; Yabanoglu S; Sinha BN; Ucar G; Basu A; Jayaprakash V Bioorg Med Chem Lett; 2010 Jan; 20(1):132-6. PubMed ID: 19945874 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]